Your browser doesn't support javascript.
loading
Self-Screening for Cervical Cancer Offered through a Digital Platform in a Region of British Columbia with Lower Screening Rates.
Smith, Laurie W; Booth, Amy; Racey, C Sarai; Smith, Brenda; Prabhakaran, Ashwini; Dabee, Smritee; Hong, Quan; Niazi, Nazia; Ogilvie, Gina S.
Afiliação
  • Smith LW; Women's Health Research Institute, Vancouver, BC V6H 3N1, Canada.
  • Booth A; BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Racey CS; Women's Health Research Institute, Vancouver, BC V6H 3N1, Canada.
  • Smith B; School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • Prabhakaran A; Island Pre-Health Science Program, North Island College, Courtenay, BC V9N 8N6, Canada.
  • Dabee S; BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Hong Q; Women's Health Research Institute, Vancouver, BC V6H 3N1, Canada.
  • Niazi N; School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • Ogilvie GS; Women's Health Research Institute, Vancouver, BC V6H 3N1, Canada.
Curr Oncol ; 31(9): 5399-5411, 2024 Sep 13.
Article em En | MEDLINE | ID: mdl-39330027
ABSTRACT
Cervical cancer is highly preventable through vaccination, early detection, and treatment, yet is the fourth most common cancer globally. HPV testing is superior to cytology for the detection of cervical pre-cancer, and jurisdictions around the world are implementing HPV primary screening, which offers the opportunity for self-screening, an important self-care intervention. Digital health solutions are also increasingly important components of self-care. In this study, we assessed the acceptability and completion of self-screening for cervical cancer offered through a digital platform within a low screening uptake region of British Columbia. The primary objective of this study was to evaluate the acceptability of self-screening for cervical cancer offered through a digital platform as measured by return rates of self-screening kits. Patients due or overdue for cervix screening were invited to participate. Eligible participants registered online to receive a self-screening kit, which included a device for vaginal self-screening, instructions, and a return envelope, sent to their home. After self-screening using the vaginal device, HPV testing was conducted. HPV-negative participants were returned to routine screening, and HPV-positive participants were recommended for cytology or colposcopy. Attendance rates at follow-up were evaluated. Participants were invited to complete an acceptability survey. From April 2019 to December 2023, 283 participants were sent kits, with 207 kits returned for a completion rate of 73%. Of valid samples (n = 202), 15 were HPV positive, and 93% attended follow-up care. Most respondents found the CervixCheck website easy to use, informative, and secure and were satisfied with receiving their results online. CervixCheck had a high completion rate among participants who were sent a self-screening kit. High compliance with recommended follow-up and high acceptability of self-screening for cervical cancer was observed. Most participants indicated they would self-screen again in the future. Innovative approaches to cervical screening, including self-screening and the use of digital health interventions, are ways to enhance equity and improve uptake of cervical screening.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Detecção Precoce de Câncer Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Detecção Precoce de Câncer Idioma: En Ano de publicação: 2024 Tipo de documento: Article